Lunit said on the 8th that it attended the "Korea-China venture startup summit," held as part of President Lee Jae-myung's visit to China. Lunit is a unicorn corporations developing medical artificial intelligence (AI).
Seo Beom-seok, Lunit CEO, proposed ways for bilateral cooperation during the "Dialogue with Korea-China venture startups" presided over by the president. Seo said, "China's AI healthcare market is projected to grow from 2.3 trillion won in 2023 to 27.5 trillion won in 2030," adding, "When the AI biomarker, which is being co-developed with 15 global big pharma companies, is released as a companion diagnostic (CDx), we are in talks to enable its use in the Chinese market."
According to Lunit, President Lee said, "If China's speed and scale are combined with Korea's credibility and safety, it will create synergy." Lee added, "As the purpose of this visit to China is for the two countries to build a future-oriented cooperative relationship, the government will also support the two countries' corporations in cooperating and achieving joint development."
The summit was held at the Shanghai International Exhibition Center under the auspices of the Ministry of SMEs and Startups. President Lee, Presidential Chief of Staff for Policy Kim Yong-bum, Deputy Prime Minister and Ministry of Science and ICT Minister Bae Kyung-hoon, Ministry of SMEs and Startups (MSS) Minister Han Seong-sook, the Chinese ambassador to Korea, and the Korean ambassador to China attended. More than 400 people attended, including tech corporations and investment industry officials from both countries.